1. Home
  2. INDP vs VINE Comparison

INDP vs VINE Comparison

Compare INDP & VINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • VINE
  • Stock Information
  • Founded
  • INDP 2000
  • VINE 2019
  • Country
  • INDP United States
  • VINE United States
  • Employees
  • INDP N/A
  • VINE N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • VINE Beverages (Production/Distribution)
  • Sector
  • INDP Health Care
  • VINE Consumer Staples
  • Exchange
  • INDP Nasdaq
  • VINE Nasdaq
  • Market Cap
  • INDP 15.4M
  • VINE 12.3M
  • IPO Year
  • INDP N/A
  • VINE 2021
  • Fundamental
  • Price
  • INDP $1.18
  • VINE $0.83
  • Analyst Decision
  • INDP Strong Buy
  • VINE
  • Analyst Count
  • INDP 1
  • VINE 0
  • Target Price
  • INDP $12.00
  • VINE N/A
  • AVG Volume (30 Days)
  • INDP 20.3K
  • VINE 329.4K
  • Earning Date
  • INDP 11-04-2024
  • VINE 11-12-2024
  • Dividend Yield
  • INDP N/A
  • VINE N/A
  • EPS Growth
  • INDP N/A
  • VINE N/A
  • EPS
  • INDP N/A
  • VINE N/A
  • Revenue
  • INDP N/A
  • VINE $1,262,487.00
  • Revenue This Year
  • INDP N/A
  • VINE N/A
  • Revenue Next Year
  • INDP N/A
  • VINE N/A
  • P/E Ratio
  • INDP N/A
  • VINE N/A
  • Revenue Growth
  • INDP N/A
  • VINE N/A
  • 52 Week Low
  • INDP $1.03
  • VINE $0.25
  • 52 Week High
  • INDP $3.25
  • VINE $1.06
  • Technical
  • Relative Strength Index (RSI)
  • INDP 37.66
  • VINE 66.68
  • Support Level
  • INDP $1.11
  • VINE $0.78
  • Resistance Level
  • INDP $1.22
  • VINE $0.94
  • Average True Range (ATR)
  • INDP 0.13
  • VINE 0.10
  • MACD
  • INDP -0.00
  • VINE 0.02
  • Stochastic Oscillator
  • INDP 28.30
  • VINE 74.55

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About VINE Fresh Vine Wine Inc.

Fresh Vine Wine Inc is a producer of low-carb, low-calorie premium wines in the United States. The company's wine collection features a California Cabernet Sauvignon, Pinot Noir, Chardonnay, California Rose wine, and a Limited Reserve Napa Cabernet.

Share on Social Networks: